SEC-sourced researchBeta

ADIA

Adia Nutrition, Inc.

US markets

Data passport

CIK: 0001160420
Exchange: OTC
Business activity: Medicinal Chemicals & Botanical Products · SIC 2833
Financial inputs: 6/6
Filing date: Oct 6, 2026
SEC registry record: Operating company

Last updated: Oct 8, 2026, 5:02 AM UTCSEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Chart metric

ADIA · Exact amounts and source periods · USD
Period end	Revenue	Filing date
December 2024	6,380.0000	Mar 31, 2026
December 2025	700,508.0000	Mar 31, 2026

Annual periods · USD

Period end	Revenue	Net income	Operating cash flow	Total assets	Total liabilities	Filing date
December 2025	700,508.0000	-395,464.0000	-179,228.0000	594,826.0000	852,500.0000	Mar 31, 2026
December 2024	6,380.0000	-181,067.0000	-335,476.0000	666,181.0000	640,641.0000	Mar 31, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

40/100

Profitability0

Growth100

Balance sheet0

Cash generation0

Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputs	USD	Period end	Filing date	Form
RevenueRevenues	$700.51K	Jan 1, 2025 – Dec 31, 2025	Mar 31, 2026	10-K
Previous period revenueRevenues	$6.38K	Jan 1, 2024 – Dec 31, 2024	Mar 31, 2026	10-K
Net incomeNetIncomeLoss	-$395.46K	Jan 1, 2025 – Dec 31, 2025	Mar 31, 2026	10-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities	-$179.23K	Jan 1, 2025 – Dec 31, 2025	Mar 31, 2026	10-K
Total assetsAssets	$594.83K	Dec 31, 2025	Mar 31, 2026	10-K
Total liabilitiesLiabilities	$852.5K	Dec 31, 2025	Mar 31, 2026	10-K

New filings

Explore methodology ↗